Philips Forms Seven-Year Strategic Alliance with WellSpan Health
Royal Philips and WellSpan Health, the leading health system in Central Pennsylvania and Northern Maryland, announced on Thursday a multi-year strategic alliance that includes joint research, technological co-development, and a commercial agreement focusing on diagnostic imaging.
Unprecedented Collaboration between Philips and an American Health Network
Philips and WellSpan Health have established a seven-year partnership that includes a research agreement and a joint innovation strategy. This collaboration is the first of its kind between Philips and an American community health system. It aims to validate the performance of new tools and technologies, particularly examining how artificial intelligence and digital solutions can enhance throughput, costs, and workflow efficiency. WellSpan has committed to reclaiming over half a million work hours annually through these advancements. The innovation component will enable WellSpan and Philips Research to co-develop new products and features. WellSpan will act both as a testing ground and co-creator, leveraging Philips' research and development portfolio to design and develop future generations of health technologies.
Diagnostic Imaging Covering the Entire Network
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Philips becomes the preferred provider for WellSpan across all applicable imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), digital radiography, ultrasound, and image-guided therapy. The agreement extends to all 12 WellSpan hospitals, as well as its diagnostic imaging centers and outpatient surgery centers. A key element of this agreement is its structured approach to technological lifecycle management. WellSpan and Philips will align equipment, services, training, and upgrade planning within a single coordinated framework, allowing greater consistency in imaging availability across sites and reducing access gaps for patients.
SectorSanté · Technologie · Dispositifs médicaux›Équipements Médicaux
Context
Period
Period: 1T2026
Key reported figures
Revenue: 3.9MD€
Free cash flow: 28M€
Guidance from the release
Nous avons délivré un bon départ en 2026.
Bonne performance au T1, croissance des ventes et des marges.
Risks mentioned
Impact des tarifs et inflation des coûts sur les marges.
Environnement macroéconomique incertain impactant les performances.
Opportunities identified
Croissance des ventes comparables de 4% dans tous les segments.
Augmentation du carnet de commandes grâce à des innovations.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.